Collins Charles Edwin IV

CEO Collins sells 13.6K shares at $610.00–$621.61 for $8.4M, reducing holdings 30.9%; stock now +40.7% in 30 days, +71.3% in 90 days.

Collins Charles Edwin IV executed two separate sales totaling 13,568 shares for $8,404,979.48 on April 20–21, 2026, reducing his stake by 30.9% from 43,888 shares to 30,320 shares. The blended average price of $619.47 sits 5.0% below the current price of $651.68, and the stock has rallied 40.7% in the past 30 days and 71.3% in the past 90 days—meaning the insider sold before a significant advance. At the same ticker (AGX), his prior 5 sales all showed positive 90-day returns (ranging from 1.5% to 24.8%), with none well-timed by the 90-day standard, indicating a consistent pattern of selling into strength rather than ahead of declines. The company trades at a P/E of 52.77 with a $9.1B market cap, and the current price of $651.68 matches the 52-week high, placing the stock at its apex—a context in which a large discretionary reduction of holdings by the CEO is observable but does not, by timing alone, constitute a predictive signal given his track record at this ticker.

AGX CEO Collins sells 10,000 shares at $309.37; stock +37.4% in 90 days, +18.6% in 30 days

Collins Charles Edwin IV, Chief Executive Officer of Gemma, sold 10,000 shares (10.0K shares) of Argan Inc at $309.37 on 2025-10-15, reducing his holdings from 31,006 shares to 21,006 shares (-32.3% reduction). The sale occurred near the stock's 52-week high of $312.50 (-9.1% from peak), in a context where AGX has appreciated 37.4% over 90 days and 18.6% over 30 days. Notably, the insiders prior four trades at this same ticker (2025-10-13, 2025-10-01, 2025-09-24, 2025-09-18) are also all sells, representing a pattern of consistent liquidation at elevated valuations. The stock is valued at a P/E of 33.44 with annual revenue growth of +52.5%, fundamental strength that may justify the run-up; his cross-ticker track record shows six prior sales with an average 30-day return of -3.3%, though same-ticker outcomes remain largely unmeasured. The timing of this liquidation—near all-time highs after strong 90-day momentum—merits close observation against the fundamental backdrop and his accumulated sale activity.

CEO of GEMMA sells 10,000 AGX shares at $292.09; stock now at $312.50 (52-week high), +30.9% in 30 days

Collins Charles Edwin IV, Chief Executive Officer of GEMMA, sold 10,000 shares of ARGAN INC at $292.09 on 2025-10-13, reducing his holdings from 31,006 shares to 21,006 shares, a decrease of 32.3%. The sale occurred when AGX was trading below the current price of $312.50, with the stock at its 52-week high and showing strong recent momentum (+30.9% over 30 days, +53.3% over 90 days). His cross-ticker track record shows 6 prior sells with an average 30-day return of -3.3%, though his prior AGX transactions remain largely unmeasurable in outcome. The timing of this sale relative to the stock's current strength—now trading at the high end of its 52-week range—presents an apparent disconnect worth examining, particularly given the company's robust fundamentals (revenue $237.7M, net income $35.3M, annual growth +52.5%, P/E 36.81).

AGX CEO Collins sells 5,000 shares at $275.00, reducing stake 19.2% to 21,006 shares post-transaction.

Collins Charles Edwin IV, CEO, executed an open-market sale of 5,000 shares at $275.00 on 2025-10-01, the highest transaction price across his recent AGX activity and near the 52-week high of $279.62. The reduction of 19.2% of his pre-transaction holdings (from 26,006 to 21,006 shares) represents a material decrease in his ownership stake at a company with strong fundamentals: annual revenue growth of +52.5%, net income of $35.3M, and a market cap of $3.6B. His prior four trades at AGX have been entirely sells over a two-month window (July 31 through September 24), with one measurable outcome showing -6.8% 30-day return on the July 31 sale. The pattern of consecutive dispositions at peak or near-peak valuations, combined with accelerating stock momentum (+15.5% in 30 days, +24.2% in 90 days), warrants examination of whether the sale reflects operational context or structural position adjustment.

CEO of Gemma sells 5,000 AGX shares at $267.00; stock near 52-week high, insider retains 21,006 shares.

Collins Charles Edwin IV, Chief Executive Officer of Gemma, sold 5,000 shares of Argan Inc. at $267.00 on 2025-09-24, reducing his holdings from 26,006 to 21,006 shares (a -19.2% reduction). The transaction occurred near the 52-week high of $268.34, with current price at $266.73. The company showed strong fundamentals: annual revenue growth of +52.5%, latest quarterly revenue of $237.7M, and net income of $35.3M, though valuation is elevated at P/E 31.42. His cross-ticker track record shows 3 prior sells with an average 30-day return of -3.3%, but prior sales at AGX have mixed outcomes (one prior sale on 2025-07-31 showed 30-day return of -6.8%; another on 2025-07-29 showed +0.2%). The sale occurs in a context of rapid recent appreciation (30-day +17.6%, 90-day +21.4%), with no measurable 90-day outcomes yet available from his two most recent AGX sales in late July and mid-September.

CEO Collins Charles Edwin IV sold 7,500 shares of AGX at $257.39 on 2025-09-18, reducing stake by 26.3% to 21,006 shares ($1.9M sale value)

Collins Charles Edwin IV, CEO of GEMMA, executed a sale of 7,500 shares at $257.39, reducing his holdings by 26.3% from 28,506 to 21,006 shares. The sale occurred just before AGX reached its 52-week high of $268.34, with the stock having appreciated 20.8% over the prior 30 days and 25.0% over 90 days. His prior trade at AGX on 2025-07-31 showed a 30-day loss of 6.8%, and the earlier trade on 2025-07-29 posted a modest 30-day gain of 0.2%, neither yet showing measurable 90-day outcomes. His cross-ticker track record across all open-market trades shows 2 prior sells with an average 30-day return of -3.3%, suggesting no established pattern of well-timed exits. The company fundamentals remain robust with annual revenue growth of +52.5%, a market cap of $3.7B, and a P/E of 31.61, limiting concern from operational weakness.

CEO Collins sold 6,500 shares for $1,587,250.00 at blended $244.19; stock now $225.27, down 8.0% from 52-week high.

Collins Charles Edwin IV, CEO of ARGAN, executed 2 separate sales totaling 6,500 shares for $1,587,250.00 on consecutive trading days (July 29 and July 31, 2025), reducing his post-transaction holdings from 21,006 shares to 14,506 shares (a -30.9% reduction). The sales occurred near the company's 52-week high, with the blended average execution price of $244.19 now trading $18.92 above the current price of $225.27. ARGAN has posted strong recent fundamentals—annual revenue growth of +52.5%, quarterly net income of $22,550,000.00, and a market cap of $3,072,865,944.51—alongside a 90-day price gain of +37.6%, suggesting the stock has appreciated substantially in the near term. The magnitude of the sale (30.9% of pre-transaction holdings) and its execution timing relative to recent price momentum constitute a material shift in the CEO's equity exposure.